Synthesis of 4-(3'-[125I]iodoanilino)-6,7-dialkoxyquinazolines: Radiolabeled epidermal growth factor receptor tyrosine kinase inhibitors

被引:0
|
作者
Lim, John K. [1 ,2 ]
Negash, Kitaw [1 ,3 ]
Hanrahan, Stephen M. [1 ]
Vanbrocklin, Henry F. [1 ]
机构
[1] Lawrence Berkeley National Laboratory, University of California, MS 55-121, 1 Cyclotron Rd., Berkeley, CA 94720, United States
[2] Department of Radiology, University of California, San Francisco, CA 94143, United States
[3] American Cyanamide Co., Agricultural Research Division, Princeton, NJ 08543, United States
关键词
Amino acids - Enzyme inhibition;
D O I
10.1002/1099-1344(20001030)43:123.0.CO;2-N
中图分类号
学科分类号
摘要
The preparation of two radioiodinated analogs of the epidermal growth factor receptor tyrosine kinase (EGFrTK) inhibitor PD153035 (4-(3'-bromoanilino)-6,7-dimethoxyquinazoline) are reported herein. The two analogs, 4-(3'-[125I]iodoanilino)-6,7-dimethoxyquinazoline and 4-(3'-[125I]iodoanilino)-6,7-diethoxyquinazoline, were synthesized via iododestannylation of the corresponding 4-(3'-trimethylstannylanilino)-6,7-dialkoxyquinazolines to form the desired I-125 labeled products in good yield, high radiochemical purity (>99%) and high specific activity.
引用
收藏
页码:1183 / 1191
相关论文
共 50 条
  • [11] Combination of 4-anilinoquinazoline and rhodanine as novel epidermal growth factor receptor tyrosine kinase inhibitors
    Li, Si-Ning
    Xu, Yun-Yun
    Gao, Jia-Yu
    Yin, Hong-ran
    Zhang, Shi-Lei
    Li, Huan-Qiu
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (13) : 3221 - 3227
  • [12] Potent 4-anilinoquinazoline inhibitors of epidermal growth factor receptor (EGFR) tyrosine kinase.
    Ghosh, S
    Liu, XP
    Narla, RK
    Jun, X
    Mao, C
    Uckun, FM
    CLINICAL CANCER RESEARCH, 1999, 5 : 3750S - 3750S
  • [13] Enantioselective inhibition of the epidermal growth factor receptor tyrosine kinase by 4-(alpha-phenethylamino)quinazolines
    Bridges, AJ
    Cody, DR
    Zhou, HR
    McMichael, A
    Fry, DW
    BIOORGANIC & MEDICINAL CHEMISTRY, 1995, 3 (12) : 1651 - 1656
  • [14] Sensitivities to various epidermal growth factor receptor-tyrosine kinase inhibitors of uncommon epidermal growth factor receptor mutations L861Q and S768I: What is the optimal epidermal growth factor receptor-tyrosine kinase inhibitor?
    Banno, Eri
    Togashi, Yosuke
    Nakamura, Yu
    Chiba, Masato
    Kobayashi, Yoshihisa
    Hayashi, Hidetoshi
    Terashima, Masato
    de Velasco, Marco A.
    Sakai, Kazuko
    Fujita, Yoshihiko
    Mitsudomi, Tetsuya
    Nishio, Kazuto
    CANCER SCIENCE, 2016, 107 (08) : 1134 - 1140
  • [15] Tyrosine kinase inhibitors .10. Isomeric 4-[(3-bromophenyl)amino]pyrido[d]-pyrimidines are potent ATP-binding site inhibitors of the tyrosine kinase function of the epidermal growth factor receptor
    Rewcastle, GW
    Palmer, BD
    Thompson, AM
    Bridges, AJ
    Cody, DR
    Zhou, HR
    Fry, DW
    McMichael, A
    Denny, WA
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (09) : 1823 - 1835
  • [17] Synthesis of modified tripeptides and tetrapeptides as potential bisubstrate inhibitors of the epidermal growth factor receptor protein tyrosine kinase
    Rosse, G
    Sequin, U
    Mett, H
    Furet, P
    Traxler, P
    Fretz, H
    HELVETICA CHIMICA ACTA, 1997, 80 (03) : 653 - 670
  • [18] SYNTHESIS AND BIOLOGICAL EVALUATION OF NOVEL PYRROLOQUINAZOLES AS POTENT EPIDERMAL GROWTH-FACTOR RECEPTOR TYROSINE KINASE INHIBITORS
    SUN, L
    SHOWALTER, HDH
    KRAKER, AJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 36 - MEDI
  • [19] Tyrosine kinase inhibitors .9. Synthesis and evaluation of fused tricyclic quinazoline analogues as ATP site inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor
    Rewcastle, GW
    Palmer, BD
    Bridges, AJ
    Showalter, HDH
    Li, S
    Nelson, J
    McMichael, A
    Kraker, AJ
    Fry, DW
    Denny, WA
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (04) : 918 - 928
  • [20] TYROSINE KINASE INHIBITORS .5. SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS FOR 4-[(PHENYLMETHYL)AMINO]-QUINAZOLINES AND 4-(PHENYLAMINO)QUINAZOLINES AS POTENT ADENOSINE 5'-TRIPHOSPHATE BINDING-SITE INHIBITORS OF THE TYROSINE KINASE DOMAIN OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR
    REWCASTLE, GW
    DENNY, WA
    BRIDGES, AJ
    ZHOU, HR
    CODY, DR
    MCMICHAEL, A
    FRY, DW
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (18) : 3482 - 3487